Tianxi Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tianxi Wang has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Cai-Xia An
School of Chemistry and Chemical Engineering, Henan Institute of Science and Technology, Xinxiang 453003, People's Republic of China
1 shared publicationGuoxi Xi
Chemistry and Environment Science College of Henan Normal University
1 shared publication- Hao Li
South China Normal University
1 shared publication - Li Yang
School of Chemistry and Chemical Engineering, Henan Institute of Science and Technology, Xinxiang, China
1 shared publication - Liyuan Niu
Henan Institute of Science and Technology
1 shared publication - Ning Zhao
Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California
1 shared publication
Latest Publications
- 13 June 2024
- Published by Elsevier in Materials Letters
- Vol. 370
Synthesis of polyaniline modified FeWO4 nanoparticles for superior visible-light photocatalysis
- 13 June 2024
- Published by Elsevier in Materials Letters
- Vol. 370
Synthesis of polyaniline modified FeWO4 nanoparticles for superior visible-light photocatalysis
- 22 September 2023
- Published by Elsevier in Materials Letters
- Vol. 353
Simple preparation of polyaniline/SiC composite as an efficient photocatalyst for the reduction of Cr(VI)
- 22 September 2023
- Published by Elsevier in Materials Letters
- Vol. 353
Simple preparation of polyaniline/SiC composite as an efficient photocatalyst for the reduction of Cr(VI)
- Open Access
- 8 December 2020
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 48 (12)
Expression and clinical significance of PTPN12 in clear cell renal cell carcinoma
Background: Clear cell renal cell carcinoma (ccRCC) is a common urological disease. Expression of the protein tyrosine phosphatase 12 gene ( PTPN12 ) is decreased in many cancers; however, the relationship between PTPN12 gene function and renal cancer remains unclear. Methods: We detected PTPN12 protein expression in ccRCC and corresponding normal tissues from 64 patients with ccRCC by immunohistochemistry, and relative PTPN12 mRNA levels by real-time quantitative polymerase chain reaction. The relationships between the relative expression levels of PTPN12 mRNA and the patients’ clinical data were analyzed. Results: PTPN12 protein and mRNA expression levels were significantly lower in ccRCC compared with the corresponding normal tissues. The mRNA expression levels in the ccRCC and corresponding normal tissues from the 64 patients with ccRCC were 0.459±0.445 and 1.001±0.128, respectively, compared with the control (glyceraldehyde 3-phosphate dehydrogenase). There was a significant correlation between relative expression of PTPN12 mRNA in ccRCC tissues and tumor diameter and clinical stage. Conclusion: The expression levels of PTPN12 protein and mRNA were significantly lower in ccRCC tissues compared with normal tissues. The role of PTPN12 may provide new insights and evidence to aid the diagnosis and targeted therapy of ccRCC.
- 8 December 2020
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 48 (12)
Open AccessExpression and clinical significance of PTPN12 in clear cell renal cell carcinoma
Background: Clear cell renal cell carcinoma (ccRCC) is a common urological disease. Expression of the protein tyrosine phosphatase 12 gene ( PTPN12 ) is decreased in many cancers; however, the relationship between PTPN12 gene function and renal cancer remains unclear. Methods: We detected PTPN12 protein expression in ccRCC and corresponding normal tissues from 64 patients with ccRCC by immunohistochemistry, and relative PTPN12 mRNA levels by real-time quantitative polymerase chain reaction. The relationships between the relative expression levels of PTPN12 mRNA and the patients’ clinical data were analyzed. Results: PTPN12 protein and mRNA expression levels were significantly lower in ccRCC compared with the corresponding normal tissues. The mRNA expression levels in the ccRCC and corresponding normal tissues from the 64 patients with ccRCC were 0.459±0.445 and 1.001±0.128, respectively, compared with the control (glyceraldehyde 3-phosphate dehydrogenase). There was a significant correlation between relative expression of PTPN12 mRNA in ccRCC tissues and tumor diameter and clinical stage. Conclusion: The expression levels of PTPN12 protein and mRNA were significantly lower in ccRCC tissues compared with normal tissues. The role of PTPN12 may provide new insights and evidence to aid the diagnosis and targeted therapy of ccRCC.
- 1 September 2011
- Published by Springer Nature in Journal of Materials Science
- Vol. 46 (18) , 6106-6110
Preparation of cobalt ferrite nanoparticles by using spent Li-ion batteries
- 1 September 2011
- Published by Springer Nature in Journal of Materials Science
- Vol. 46 (18) , 6106-6110
Preparation of cobalt ferrite nanoparticles by using spent Li-ion batteries